Understanding Gene Editing
February 12, 2025Information
- ID
- 12733
- To Cite
- DCA Citation Guide
Transcript
- 00:05Gene is a piece of
- 00:06the DNA we call blueprint
- 00:08for life.
- 00:10DNA or gene give instruction
- 00:13that goes to the mRNA,
- 00:14then mRNA
- 00:15translate to the protein.
- 00:18The protein pretty much responsible
- 00:20for all our biological
- 00:22functions.
- 00:23That's in how we work
- 00:24because our protein.
- 00:26Our gene determines which protein
- 00:28to be expressed.
- 00:30Every cell you have to
- 00:31have
- 00:32a sort of DNA
- 00:34to make the cell functions.
- 00:36But cells in different organs,
- 00:37different tissues, they
- 00:39express certain subset of genes.
- 00:44The genetic variant can cause
- 00:46called a personal trait,
- 00:48which is neutral benign.
- 00:50But some of them are
- 00:51crucial for our health. If
- 00:53that particular variant
- 00:55end up in a very
- 00:56critical part of the gene
- 00:58We may produce a faulty
- 01:00protein
- 01:01or, you know, we cannot
- 01:03produce a specific protein at
- 01:05all.
- 01:06That became disease causing. Oftentimes,
- 01:09we commutation.
- 01:10For some genetic disease, you
- 01:12know,
- 01:12the cause could be very
- 01:14complicated. Without understanding the mechanism,
- 01:16it's certainly very difficult to
- 01:18design any, treatment.
- 01:23Gene editing can modulate or
- 01:25correct a gene,
- 01:27which you believe in causing
- 01:28disease.
- 01:29It's a very powerful tool
- 01:31which could be used to
- 01:32produce the
- 01:33the right form of protein,
- 01:35which respond for most, biological
- 01:38functions.
- 01:39Before, there is no tool
- 01:42can do this job very,
- 01:43very efficiently.
- 01:45Even somebody carries a genetic
- 01:47variance,
- 01:48this genetic variance may not
- 01:49affect all cells or tissues.
- 01:52When CRISPR coming, so this
- 01:55became a reality.
- 01:57So you can editing or
- 01:58correct the gene very efficient
- 02:00way.
- 02:01Basically, you can target at
- 02:03the specific cells.
- 02:04So there's a lot of
- 02:05advantages that makes CRISPR,
- 02:08so revolutionary.
- 02:09And then, you know, now
- 02:10a lot of, people, including
- 02:12us,
- 02:13try to use this technology
- 02:15to, you know, to treat
- 02:16genetic disease.
- 02:22Pretty much the biological structure
- 02:24of the brain makes drug
- 02:25delivery to the brain. This
- 02:26case deliver genome medicines to
- 02:28the brain. Very, very challenging.
- 02:31This very innovative technology,
- 02:33in short we call STAP,
- 02:34allow
- 02:35us to deliver
- 02:37the crisp editing
- 02:38more efficient
- 02:40to the brain.
- 02:42Basically, it's a technology based
- 02:43on the use of small
- 02:45molecules to deliver protein based
- 02:47genome editing machinery.
- 02:50We have developed a thousand
- 02:52of stuff molecules already.
- 02:54So we screen those stuff
- 02:56molecules.
- 02:57We found certain stuff molecules
- 02:59like a specific cell type.
- 03:02They enable,
- 03:03deliver all the CRISPR machinery
- 03:06into the brain and dispose
- 03:08the swabs brain. So that's
- 03:09very unique.
- 03:12We have five thousand disease.
- 03:13We know the mechanism,
- 03:14but
- 03:15each one may have a
- 03:16different mechanism. So therefore,
- 03:19individual disease, you may have
- 03:22developed individual
- 03:23sort of for the tool,
- 03:24even under the umbrella for
- 03:26the CRISPR editing.
- 03:28So far, I think we
- 03:29used the Cas9
- 03:31for the disease we're working
- 03:32on right now. It's Angelman
- 03:34syndrome. That potentially can
- 03:36apply to a few hundred
- 03:38other new genetic disease.
- 03:41Our hope is that in
- 03:42the next few years with
- 03:44the support from NIOSH,
- 03:46we can move this stuff
- 03:47based therapy into clinic.
- 03:51But stuff technology is a
- 03:52platform technology,
- 03:54which means that we can,
- 03:56potentially adapt this technology,
- 03:58for deliver our other, payloads
- 04:01to other cells and tissues.
- 04:05That means in long term,
- 04:06we hope, this technology
- 04:08can be repurposed enough for
- 04:10treatment of many other rare
- 04:11disease.